Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuanmai Ganjie is a traditional Chinese medicine (TCM) granule formulation developed by Jiangsu Tiansheng Pharmaceutical for the treatment of throat and respiratory conditions, specifically pharyngitis. The formula is a classic TCM combination consisting of four primary herbal ingredients: *Scrophularia ningpoensis* (Xuan Shen), *Ophiopogon japonicus* (Mai Dong), *Glycyrrhiza uralensis* (Gan Cao), and *Platycodon grandiflorus* (Jie Geng). It functions by nourishing Yin, clearing heat, and soothing the throat, making it effective for symptoms such as sore throat, dry mouth, and inflammation of the pharynx. The product is approved for marketing in China and is administered orally.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xuanmai ganjie.